Arcturus Therapeutics Holdings (ARCT) Debt to Equity: 2018-2025
Historic Debt to Equity for Arcturus Therapeutics Holdings (ARCT) over the last 4 years, with Mar 2025 value amounting to $0.06.
- Arcturus Therapeutics Holdings' Debt to Equity was N/A to $0.06 in Q1 2025 from the same period last year, while for Mar 2025 it was $0.06, marking a year-over-year change of. This contributed to the annual value of $0.22 for FY2022, which is 18.86% down from last year.
- Per Arcturus Therapeutics Holdings' latest filing, its Debt to Equity stood at $0.06 for Q1 2025, which was down 10.14% from $0.07 recorded in Q3 2023.
- In the past 5 years, Arcturus Therapeutics Holdings' Debt to Equity registered a high of $0.41 during Q3 2022, and its lowest value of $0.06 during Q1 2025.
- In the last 2 years, Arcturus Therapeutics Holdings' Debt to Equity had a median value of $0.07 in 2023 and averaged $0.07.
- As far as peak fluctuations go, Arcturus Therapeutics Holdings' Debt to Equity surged by 626.46% in 2021, and later tumbled by 82.59% in 2023.
- Over the past 4 years, Arcturus Therapeutics Holdings' Debt to Equity (Quarterly) stood at $0.28 in 2021, then decreased by 18.86% to $0.22 in 2022, then slumped by 82.59% to $0.07 in 2023, then reached $0.06 in 2025.
- Its Debt to Equity stands at $0.06 for Q1 2025, versus $0.07 for Q3 2023 and $0.22 for Q4 2022.